The remuneration committee is comprised of René Spogárd (chairman) and Peter Benson. The remuneration committee’s role is primarily to prepare matters regarding remuneration and other terms of employment for the CEO and other senior executives. The remuneration committee shall also monitor and evaluate ongoing and completed programs for variable remuneration to the Ascelia Pharma’s management and to monitor and evaluate the implementation of the guidelines for remuneration to senior executives which the Annual General Meeting has adopted.
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development. Ascelia Pharma has global headqu ...
Ascelia’s employees are passionate and driven to develop products that will help people with rare cancer conditions live longer and healthier lives.
Our values inspire our ambitions, decision making and collaboration to help us reach our highest potential. INTEGRITY We build powerful relationship with mutual respect and adhere to the high ethical standards of our industry COURAGE We work tirelessly and follow our convictions even when it means changing status quo FOCUS We are devoted to i ...